Cytomegalovirus (CMV) infection remains a significant challenge in solid organ
transplantation (SOT). The last international consensus guidelines on the management of …

Utilizing assays that assess specific T-cell-mediated immunity against cytomegalovirus
(CMV) holds the potential to enhance personalized strategies aimed at preventing and …

Cytomegalovirus (CMV) is one of the most important opportunistic infections in solid organ
transplant (SOT) recipients. However, current techniques used to predict risk for CMV …

The past 1–2 years have seen major developments in the area of CMV management in
transplant recipients. Expanding diagnostic and therapeutic capabilities provide a …

Solid organ transplant recipients (SOTRs) are at high risk of human herpesvirus (HHV)-
related morbidity and mortality due to the use of immunosuppressive therapy. We aim to …

Cytomegalovirus (CMV) is one of the most common infections occurring after solid organ
transplantation. This high burden of disease, which incurs sizeable morbidity, may be …

Human cytomegalovirus (CMV) infection, which is one of the most common complications in
transplant recipients, increases the risk of graft loss and rejection. Laboratory strategies for …

Introduction Risk stratification for CMV infection in lung transplantation (LT) currently relies
on determining donor and recipient CMV IgG before transplantation. However, it has been …

Introduction Cytomegalovirus (CMV) causes significant morbidity in solid organ transplant
recipients (SOTR). Measuring cell‐mediated immunity (CMI) may inform the risk of CMV …

Introduction Cytomegalovirus (CMV) is a common opportunistic infection after solid organ
transplantation, with significant impact on morbidity and long-term survival. Despite …